Delivery Order SPE2DB20D7059-SPE2DB25FQFJ3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,789.72 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a delivery order valued at $5,854.98 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) on May 30, 2025, with completion scheduled for June 2, 2025. This is a firm fixed-price delivery order issued under a competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution...
- The Defense Logistics Agency (DLA) awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $5,218.79. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,580.74 to AmerisourceBergen Drug Corp for the supply of Topiramate 50 mg tablets (1,000 count) under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,281.58 to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) with a firm fixed price contract type. This award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation and was competitively awarded. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Topiramate 50 mg tablets in quantities of 1,000 units, valued at $2,393.22 with a firm fixed-price structure. This award represents a non-competed delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $2,012.44 and a firm fixed price contract type. This delivery order represents a non-set-aside, competitively awarded procurement and is scheduled for completion by May 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,099.68 from the Defense Logistics Agency's Medical Supply Chain to supply 1,000 units of Topiramate 25mg. The contract was competitively awarded on June 7, 2025, with a firm fixed price structure and no set-aside designation. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,055.46, is for the delivery of 25 mg topiramate tablets. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $3,471.53 to AmerisourceBergen Drug Corp for the supply of Topiramate ER 100 mg capsules (30-count) with a completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on October 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQFJ3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Topiramate 25 mg tablets (500 count) under a firm fixed-price contract valued at $3,579.40. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply chain needs, particularly for military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The underlying IDC serves as a flexible contracting vehicle enabling the company to supply critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This transaction reflects the company's continued role as a key vendor within the DLA's pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 4/30/25 |